{"id":"W2515998798","doi":"10.1016/j.clinthera.2016.07.010","title":"Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study","year":2016,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Teva Pharmaceutical Industries; Genentech; GlaxoSmithKline","keywords":"Mepolizumab; Medicine; Asthma; Term (time); Open label; Adverse effect; Internal medicine; Eosinophil","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002774124,0.001316217,0.001908047,0.0002501787,0.0004687912,0.0008763018,0.0007114194,0.001078897,0.002473658],"category_scores_gemma":[0.0009724448,0.0004744086,0.00132708,0.0002710628,0.0007727804,0.0007295398,0.0003266057,0.002342336,0.0008230191],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005372145,"about_ca_system_score_gemma":0.001052522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004272289,"about_ca_topic_score_gemma":0.001024187,"domain_scores_codex":[0.9992781,0.0003460424,0.00005937058,0.0001227439,0.000106467,0.00008724897],"domain_scores_gemma":[0.9986799,0.0001917181,0.0003749021,0.000124546,0.0001113491,0.0005175305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7411057,0.07496299,0.02100841,0.001473134,0.003826101,0.0003777474,0.0004713236,0.001319381,0.06695589,0.0001323244,0.003604531,0.08476236],"study_design_scores_gemma":[0.6097988,0.3155453,0.06709425,0.00005728845,0.0009301911,0.0004811504,0.00008059129,0.001048312,0.003058594,0.00007437633,0.001787304,0.00004381163],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961764,0.001620205,0.000292249,0.0001692618,0.00003710848,0.0007582134,0.0005161671,0.00003498501,0.000395408],"genre_scores_gemma":[0.9936407,0.001124846,0.0009714809,0.0006047009,0.0001658142,0.001438127,0.001218189,0.00001492447,0.0008211826],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002774124,"threshold_uncertainty_score":0.01467115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1029739026257499,"score_gpt":0.4248186128161392,"score_spread":0.3218447101903893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}